Impact of calculated plasma volume status on all-cause and cardiovascular mortality: 4-year nationwide

Yoichiro Otaki1, Tetsu Watanabe1, Tsuneo Konta1

  • 1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

Plos One
|August 21, 2020
PubMed

Insights

Plasma volume status (PVS) is a significant risk factor for mortality in the general population. This study found that both high and low PVS independently predict all-cause and cardiovascular deaths, suggesting PVS is a crucial health marker.

Area of Science:

  • Cardiology
  • Public Health
  • Biostatistics

Background:

  • Plasma volume status (PVS) is increasingly recognized for its role in cardiovascular disease, particularly heart failure management.
  • The association between abnormal PVS and mortality risk in the general population remains unclear.
  • PVS quantifies plasma volume expansion and contraction.

Purpose of the Study:

  • To investigate the association between plasma volume status (PVS) and all-cause and cardiovascular mortality.
  • To determine if PVS is an independent risk factor for mortality in a large general population cohort.

Main Methods:

  • Utilized a nationwide Japanese health check-up database of 230,882 adults aged 40-75 years (2008-2011).
  • Followed subjects for four years, recording all-cause, cardiovascular, and non-cardiovascular deaths.
  • Defined high and low PVS using specific thresholds (≥ 7 and < -13.3, respectively) and employed multivariate Cox regression analysis.

Main Results:

  • High PVS was identified as an independent risk factor for all-cause, cardiovascular, and non-cardiovascular mortality.
  • Low PVS was a risk factor for cardiovascular deaths but a negative risk factor for non-cardiovascular deaths.
  • Incorporating PVS into existing cardiovascular risk models significantly improved predictive accuracy.

Conclusions:

  • This study provides the first prospective evidence linking PVS to all-cause and cardiovascular mortality in the general population.
  • Abnormal plasma volume status (both high and low) represents an additional, significant risk factor for mortality.
  • PVS measurement may enhance risk stratification for cardiovascular events and overall mortality.
Abstract

Related Concept Videos

Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
2.7K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
653
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
307
Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac...
4.2K
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
221
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.1K